IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNFalpha
申请人:CELGENE CORPORATION
公开号:EP0797437B1
公开(公告)日:2001-04-18
NOVEL IMMUNOTHERAPEUTIC IMIDES/AMIDES
申请人:CELGENE CORPORATION
公开号:EP0942902A2
公开(公告)日:1999-09-22
US5703098A
申请人:——
公开号:US5703098A
公开(公告)日:1997-12-30
[EN] NOVEL IMMUNOTHERAPEUTIC IMIDES/AMIDES<br/>[FR] IMIDES/AMIDES A VOCATION IMMUNOTHERAPIQUE
申请人:——
公开号:WO1998024763A2
公开(公告)日:1998-06-11
[EN] Novel imide/amide ethers and alcohols are inhibitors of cytokines including tumor necrosis factor alpha and can be used to combat cachexia, endotoxic shock, arthritis, asthma, and retrovirus replication. A typical embodiment is 3-phthalimido-3-(3',4'-dimethoxyphenyl)propan-1-ol. [FR] La présente invention concerne de nouvelles formes d'imides/amides éthers et alcools inhibitrices de cytokines, y compris du facteur de nécrose tumorale alpha . Ces nouvelles formes conviennent particulièrement contre la cachexie, le choc endotoxique, l'arthrite, l'asthme et la réplication rétrovirale. L'une des formes particulières de l'invention est le 3-phthalimido-3-(3',4'-diméthoxyphényl)propane-1-ol.
Immunotherapeutic imides/amides
申请人:Celgene Corporation
公开号:US05703098A1
公开(公告)日:1997-12-30
Imide/amide ethers and alcohols are inhibitors of cytokines including tumor necrosis factor .alpha. and can be used to combat cachexia, endotoxic shock, arthritis, asthma, and retrovirus replication. A typical embodiment is 3-Phthalimido-3-(3', 4'-dimethoxyphenyl)propan-1-ol.